cangrelor has been researched along with Kidney-Failure--Chronic* in 3 studies
3 other study(ies) available for cangrelor and Kidney-Failure--Chronic
| Article | Year |
|---|---|
Heparin-Induced Thrombocytopenia and Cardiac Surgery: Can We Do It All With Cangrelor?
Topics: Adenosine Monophosphate; Cardiopulmonary Bypass; Heparin; Humans; Kidney Failure, Chronic; Thrombocytopenia | 2019 |
In Response.
Topics: Adenosine Monophosphate; Cardiopulmonary Bypass; Heparin; Humans; Kidney Failure, Chronic; Thrombocytopenia | 2019 |
Successful Use of Cangrelor and Heparin for Cardiopulmonary Bypass in a Patient With Heparin-Induced Thrombocytopenia and End-Stage Renal Disease: A Case Report.
Heparin is the only well-established anticoagulant medication for cardiopulmonary bypass making selecting an alternative anticoagulant challenging in patients with heparin-induced thrombocytopenia. Other anticoagulant medications can cause significant postoperative bleeding, especially in patients with end-stage renal disease. We present a case of a 63-year-old woman requiring aortic valve replacement with a history of heparin-induced thrombocytopenia and end-stage renal disease. Cangrelor and heparin were successfully used during cardiopulmonary bypass, offering an option for anticoagulation management for a uniquely challenging patient population. Topics: Adenosine Monophosphate; Cardiopulmonary Bypass; Female; Heart Valve Prosthesis Implantation; Heparin; Humans; Intraoperative Care; Kidney Failure, Chronic; Middle Aged; Thrombocytopenia; Treatment Outcome | 2019 |